Company Filing History:
Years Active: 1999
Title: Wilfrid Jacques: Innovator in Pharmaceutical Technology
Introduction
Wilfrid Jacques is a notable inventor based in Longueuil, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release tablets. His innovative approach has the potential to enhance the effectiveness of medications.
Latest Patents
Wilfrid Jacques holds a patent for a pharmaceutical controlled release tablet that contains a carrier made of cross-linked amylose. This patent, which is a significant advancement in drug delivery systems, incorporates hydroxymethylpropylcellulose (HPMC) with a viscosity higher than or equal to 4000 cps as an adjuvant. The addition of HPMC allows for better control over the effect of enzymes, specifically alpha-amylase, present in the intestinal medium. This innovation reduces the dependence of the kinetics of release on the concentration of enzymes in the medium, thereby improving the reliability of the medication's release profile.
Career Highlights
Wilfrid Jacques has dedicated his career to advancing pharmaceutical technologies. His work at Labopharm Inc. has been instrumental in developing innovative drug delivery systems that improve patient outcomes. His expertise in the field has led to the successful patenting of his groundbreaking work.
Collaborations
Wilfrid has collaborated with various professionals in the pharmaceutical industry, including his coworker Francois Chouinard. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.
Conclusion
Wilfrid Jacques is a prominent figure in the pharmaceutical industry, known for his innovative contributions to controlled release technology. His patent for pharmaceutical controlled release tablets showcases his commitment to improving drug delivery systems. His work continues to influence the field and enhance patient care.